[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354899-105":59,"doc-detail-354899-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","loxl2-cancer-associated-fibroblasts-shape-wnt-signaling-to-drive-chemoresistance-and-poor-outcomes-in-colorectal-cancer-insights-from-multi-omics-and-epidemiological-analyses","LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses","","Cancer-associated fibroblasts (CAFs) critically influence colorectal cancer (CRC) progression and therapy response, yet their epidemiological and molecular heterogeneity remains insufficiently characterized. This study integrates bulk, single-cell, and spatial transcriptomic datasets across multiple CRC cohorts with patient-derived tissues and functional assays to define CAF subtypes and clinical significance. Results identify LOXL2⁺ CAFs enriched in advanced, chemoresistant CRC, linked to WNT activation, stemness, and poor survival, with LOXL2/WNT5A inhibition restoring chemosensitivity and suppressing tumor growth.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/loxl2-cancer-associated-fibroblasts-shape-wnt-signaling-to-drive-chemoresistance-and-poor-outcomes-in-colorectal-cancer-insights-from-multi-omics-and-epidemiological-analyses/354899/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/loxl2-cancer-associated-fibroblasts-shape-wnt-signaling-to-drive-chemoresistance-and-poor-outcomes-in-colorectal-cancer-insights-from-multi-omics-and-epidemiological-analyses/354899.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What CAF subtype is highlighted in this study?","Question",{"text":112,"@type":113},"The study identifies a myofibroblastic CAF (myCAF) subset with high LOXL2 expression as a consistent feature across advanced and chemoresistant CRC samples.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do LOXL2⁺ CAFs affect WNT signaling and chemoresistance?",{"text":117,"@type":113},"LOXL2⁺ CAFs activate WNT signaling in adjacent tumor cells, promoting stemness and drug resistance, including interactions involving WNT5A-positive cancer cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports LOXL2 as a prognostic biomarker?",{"text":121,"@type":113},"Across population-based cohorts, elevated LOXL2 expression is independently associated with poor overall survival and disease-free survival, supported by multivariate Cox regression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354899,1790809468,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Neoplasia 72 (2026) 101267  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses |  |  | |\n| --- | --- | --- | --- |\n| Chengyuan Xu a,1, Tengfei Lia,1, Lin Zhang b,1, Qin Zhang a, Shanshan Caic,*,1 , Qiangqiang Fud,*,1, Siqi Zhang b,*,1 \u003Cbr>a Yangpu Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China b Department of Pharmacy, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, 200090, China\u003Cbr>c Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YG, United Kingdom d Yangpu Hospital, School of Medicine, Tongji University, 200090, China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Colorectal cancer Multi-omics analysis LOXL2+CAFs Drug resistance WNT |  | Background: Cancer-associated fibroblasts (CAFs) critically influence colorectal cancer (CRC) progression and therapy response, yet their epidemiological and molecular heterogeneity remains underexplored.\u003Cbr>Methods: We integrated bulk, single-cell, and spatial transcriptomic datasets from multiple CRC cohorts, together with patient-derived tissues and functional assays, to delineate CAF subtypes and their clinical significance. Epidemiological analyses were performed across independent cohorts to evaluate the association between CAF markers and patient outcomes.\u003Cbr>Results: A myofibroblastic CAF (myCAF) subset characterized by high LOXL2 expression was consistently enriched in advanced and chemoresistant CRC samples. Multi-omics correlation analyses revealed that LOXL2⁺ CAFs activated WNT signaling in adjacent tumor cells, promoting stemness and drug resistance. Across population-based cohorts, elevated LOXL2 expression was independently associated with poor overall and disease-free survival, as confirmed by multivariate Cox regression. Spatial transcriptomics and immunofluorescence demonstrated close physical interaction between LOXL2⁺ CAFs and WNT5A-positive cancer cells. Functional inhibition or genetic silencing of LOXL2 and wnt5a in CAFs restored chemosensitivity in vitro and suppressed tumor growth in vivo.\u003Cbr>Conclusions: Our integrative epidemiological and experimental analyses identify LOXL2⁺ CAFs as a key stromal determinant of chemoresistance and poor prognosis in CRC. These findings highlight a clinically relevant stromal biomarker with potential for risk stratification and therapeutic targeting in colorectal cancer. |  |\n\nIntroduction  \nColorectal cancer (CRC) is a leading cause of cancer-related mortality, resulting in nearly 90,000 deaths per year [1]. Colon cancers  \naccount for ~70% of CRC, while rectal cancers represent ~30%[2]. Both can disseminate rapidly without treatment, leading to poor outcomes [3]. Standard therapies include surgery, targeted therapy, neoadjuvant radiotherapy, and adjuvant chemotherapy, yet drug resistance  \nAbbreviation: OS, overall survival; RFS, recurrence-free survival, PSS, post-progression survival; GSEA, gene get enrichment analysis; DEGs, differentially expressed genes; RT-qPCR, quantitative real-time polymerase chain reaction; IHC, immunohistochemistry; WB, western blotting; ROC, receiver operating characteristic curves; CRC, colorectal cancer; GO, Gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; EMT, epithelial–mesenchymal transition; scRNA-seq, single-cell RNA sequencing; Mye, myeloid cells; Epi, epithelial cells; ST, spacial transcription; CAFs, cancer-associated fibroblasts; CR, complete responders; NR, nonresponders; PR, partial responders; PRET, pre-treatment; POSTN, post-treatment non-responder; POSTT, post-treatment Responder; CMA, ","cbCaigMVdZK3C7tr","https://ap.wps.com/l/cbCaigMVdZK3C7tr","pdf",18425756,14,"English","# Introduction\n# Methods\n# Results\n## CAF subtypes and LOXL2⁺ myCAF enrichment\n## LOXL2⁺-WNT activation and clinical association\n## Spatial interaction and functional validation\n# Conclusions","[{\"question\":\"What CAF subtype is highlighted in this study?\",\"answer\":\"The study identifies a myofibroblastic CAF (myCAF) subset with high LOXL2 expression as a consistent feature across advanced and chemoresistant CRC samples.\"},{\"question\":\"How do LOXL2⁺ CAFs affect WNT signaling and chemoresistance?\",\"answer\":\"LOXL2⁺ CAFs activate WNT signaling in adjacent tumor cells, promoting stemness and drug resistance, including interactions involving WNT5A-positive cancer cells.\"},{\"question\":\"What evidence supports LOXL2 as a prognostic biomarker?\",\"answer\":\"Across population-based cohorts, elevated LOXL2 expression is independently associated with poor overall survival and disease-free survival, supported by multivariate Cox regression.\"}]","LOXL2⁺ cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: Insights from multi-omics and epidemiological analyses | PDF",1790114708,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f31c2ce9a0cd92be48e5086a2f56c117.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/265d19bb8243c85c4727c3a9c0ae8d9d.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/395c4a6a3a9908c5d5daefd873f5df1c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f66811ade6988bd885210d179f1e7c7.webp",980,1306]